1. Home
  2. DLPN vs HBIO Comparison

DLPN vs HBIO Comparison

Compare DLPN & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • HBIO
  • Stock Information
  • Founded
  • DLPN 1996
  • HBIO 1901
  • Country
  • DLPN United States
  • HBIO United States
  • Employees
  • DLPN N/A
  • HBIO N/A
  • Industry
  • DLPN Other Consumer Services
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • DLPN Consumer Discretionary
  • HBIO Industrials
  • Exchange
  • DLPN Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • DLPN 11.4M
  • HBIO 13.0M
  • IPO Year
  • DLPN N/A
  • HBIO 2000
  • Fundamental
  • Price
  • DLPN $1.09
  • HBIO $0.32
  • Analyst Decision
  • DLPN Strong Buy
  • HBIO Buy
  • Analyst Count
  • DLPN 1
  • HBIO 2
  • Target Price
  • DLPN $5.00
  • HBIO $4.50
  • AVG Volume (30 Days)
  • DLPN 12.9K
  • HBIO 308.3K
  • Earning Date
  • DLPN 05-20-2025
  • HBIO 05-12-2025
  • Dividend Yield
  • DLPN N/A
  • HBIO N/A
  • EPS Growth
  • DLPN N/A
  • HBIO N/A
  • EPS
  • DLPN N/A
  • HBIO N/A
  • Revenue
  • DLPN $51,684,984.00
  • HBIO $94,135,000.00
  • Revenue This Year
  • DLPN $2.62
  • HBIO N/A
  • Revenue Next Year
  • DLPN $22.65
  • HBIO $8.58
  • P/E Ratio
  • DLPN N/A
  • HBIO N/A
  • Revenue Growth
  • DLPN 19.86
  • HBIO N/A
  • 52 Week Low
  • DLPN $0.75
  • HBIO $0.33
  • 52 Week High
  • DLPN $2.78
  • HBIO $4.08
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 54.86
  • HBIO 28.99
  • Support Level
  • DLPN $1.00
  • HBIO $0.29
  • Resistance Level
  • DLPN $1.16
  • HBIO $0.40
  • Average True Range (ATR)
  • DLPN 0.06
  • HBIO 0.03
  • MACD
  • DLPN 0.00
  • HBIO 0.01
  • Stochastic Oscillator
  • DLPN 58.76
  • HBIO 19.23

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Share on Social Networks: